Table 1.
Demographic and Clinical Characteristics by Diagnostic Group
Variable | CTL (n = 39) |
MDD (n = 41) |
Difference Test |
---|---|---|---|
Demographic characteristics | |||
Age (M, SD) | 31.8 (9.7) | 35.4 (9.8) | t(78)=−1.67, p=.10 |
Gender (% women) | 82.1% | 78.0% | χ2(1)=0.20, p=.66 |
Race/Ethnicitya | χ2(5)=3.89, p=.56 | ||
African American | 2.6% | 5.0% | |
American Indian/Alaska Native | 2.6% | 0% | |
Asian American | 15.4% | 20.0% | |
Caucasian | 59.0% | 62.5% | |
Hispanic/Latino | 5.1% | 7.5% | |
Other/Multiracial | 15.4% | 5.0% | |
Education | χ2(3)=5.89, p=.12 | ||
High school or lower | 0% | 7.3% | |
Some college | 33.3% | 34.1% | |
Bachelor’s degree | 48.7% | 29.3% | |
Professional degree | 17.9% | 29.3% | |
Marital Status | χ2(2)=4.62, p=.10 | ||
Never married | 56.4% | 39.0% | |
Married or cohabiting | 38.5% | 41.5% | |
Previously married | 5.1% | 19.5% | |
Clinical characteristics | |||
Current MDE severityb | |||
Mild | n/a | 5.0% | |
Moderate | n/a | 75.0% | |
Severe | n/a | 20.0% | |
Global assessment of functioningc | 87.3 (6.4) | 55.4 (7.6) | t(75)=19.80, p<.001 |
Current comorbid anxiety disorder | 0% | 63.4% | χ2(1)=33.10, p<.001 |
Taking psychotropic medication | 2.6% | 31.7% | χ2(1)=11.76, p=.001 |
Note. CTL = healthy control; MDD = major depressive disorder; MDE = major depressive episode; n/a = not applicable.
One MDD participant did not report her race/ethnicity.
Percentages reported for MDE severity correspond to data from 40 out of 41 MDD participants.
Means reported for global assessment of functioning correspond to data from 37 out of 39 CTL participants and 40 out of 41 MDD participants.